Wird geladen...

Explaining The Cost Of Biotech Therapies

Health plans and employers are strategizing about how to finance biotech therapies, which can run five and six figures per patient per year. The challenge to manufacturers is to communicate the value of their products now – before someone defines it for them.

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: EDELMAN, BILL
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioCommunications LLC 2004
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3555164/
https://ncbi.nlm.nih.gov/pubmed/23372497
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!